Iterum Therapeutics plc (NASDAQ: ITRM) rose 30.1% to $1.60 in pre-market trading after the company issued an update on NDA review for sulopenem etzadroxil/probenecid. Mannatech, Inc. (NASDAQ: MTEX) rose 25.3% to $25.00 in pre-market trading after the company announced intent to commence a cash tender offer to purchase up to 211,538 shares of its common stock at $26 per share. Moxian, Inc. (NASDAQ: MOXC) rose 20.4% to $20.40 in pre-market trading. MOGU Inc. (NYSE: MOGU) shares rose 16.3% to $1.78 in pre-market trading after reporting Q4 results. Yext, Inc. (NYSE: YEXT) rose 10.4% to $13.59 in pre-market trading after the company reported better-than-expected Q1 results and issued strong revenue guidance . AMC Entertainment Holdings, Inc. (NYSE: AMC) shares rose 10.2% to $29.24 in pre-market trading. AMC jumped over 35% on Thursday as retail traders continue to band together in an attempt to squeeze the stock higher. Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) rose 7.4% to $86.36 in pre-market trading after the company reported better-than-expected Q1 results. Hudson Technologies, Inc. (NASDAQ: HDSN) rose 6.9% to $2.98 in pre-market trading. Hudson Technologies, earlier during the month, reported better-than-expected Q1 results. Aqua Metals, Inc. (NASDAQ: AQMS) rose 6.2% to $3.26 in pre-market trading after jumping 20% on Thursday. Q&K International Group Limited (NASDAQ: QK) rose 5.6% to $1.13 in pre-market trading. Express, Inc. (NYSE: EXPR) rose 5.5% to $5.07 in pre-market trading after a 13G filing showed DE Shaw has a 5% stake in the company. Koss Corporation (NASDAQ: KOSS) rose 5.2% to $24.03 in pre-market trading. Koss shares jumped over 10% on Thursday amid continued speculative retail trading in the name. salesforce.com, inc. (NYSE: CRM) rose 4.7% to $236.50 in pre-market trading after the company reported better-than-expected results for its first quarter. The company issued strong forecast for the current quarter and also raised its FY22 guidance. Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares rose 4.6% to $6.85 in pre-market trading. The company recently published a trial titled “A Trial to Learn More About a Possible Treatment For Participants With Acute Myeloid Leukemia” to ClinicalTrials.gov. Nabriva Therapeutics plc (NASDAQ: NBRV) rose 4.3% to $1.46 in pre-market trading. Nabriva Therapeutics and Sinovant Sciences, recently, announced topline results from the Phase 3 trial of lefamulin in Chinese adults with community acquired bacterial pneumonia. Ulta Beauty, Inc. (NASDAQ: ULTA) rose 3.6% to $340.16 in pre-market trading after the company reported better-than-expected Q1 sales and raised FY21 guidance. Veeva Systems Inc (NYSE: VEEV) rose 3.5% to $274.02 in pre-market trading after the company reported better-than-expected Q1 results and issued Q2 FY21 guidance above estimates.
Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.
1847 Goedeker Inc. (NASDAQ: GOED) shares fell 68.7% to $1.90 in pre-market trading. 1847 Goedeker shares jumped over 40% on Thursday on abnormally-high volume. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) shares fell 7% to $1.90 in pre-market trading after jumping around 10% on Thursday. Marathon Digital Holdings, Inc. (NASDAQ: MARA) fell 5.6% to $24.39 in pre-market trading. B. Riley recently initiated coverage on the stock with a Buy rating and a $47 price target. GSX Techedu Inc. (NYSE: GOTU) fell 5.6% to $18.11 in pre-market trading. GSX Techedu recently reported worse-than-expected Q1 EPS. Bit Digital, Inc. (NASDAQ: BTBT) fell 5.4% to $8.92 in pre-market trading after gaining over 4% on Thursday. HP Inc. (NYSE: HPQ) fell 5.3% to $30.40 in pre-market trading. HP reported upbeat results for its fiscal second quarter and raised its FY21 earnings forecast. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) fell 4.6% to $2.31 in pre-market trading after dropping 10% on Thursday.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.